"In SPRINT, those with lower baseline CVD risk had more harm than benefit from intensive treatment, whereas those with higher risk had more benefit" #PrimumNonNocere #DontTreatLowRisc #ThinkAboutHarms #DontOverTreat
New NNT→Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension. https://t.co/P4COJBiHuR
RT @GWOIMH: Evaluating Risk Factors May Help in Recommending #Hypertension Treatment Guidelines. via @imconsortium #GWSMHS https://t.co/4wE…
Evaluating Risk Factors May Help in Recommending #Hypertension Treatment Guidelines. via @imconsortium #GWSMHS https://t.co/4wEh7HIl43 https://t.co/qz5f3yYgSY
@AHAScience a) "Recommend *any [older pts]* with average SPB >130 be treated ...to below 130" ..."they don't get a lot of falls" b) no definition of "older" c) no NNT/NNH (or even RRR) given d) see Phillips at al conclusion* e) promoted tweet (*https:/
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/viEO7XFnSg
Interesting paper looking at benefit/harm ratios using #SPRINT data. However, relies on point estimates to make final conclusions. Hazard reductions for treatment stable across quartiles. HR for SAE minimal with wide CI. https://t.co/2R2iwWMVYC https://t.c
RT @JCosinSales: Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/wkJTwAb…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @Steph_Achenbach: Benefit of low RR target linked to baseline CV risk: SPRINT (published 2015) in n=9361 showed benefit of targeting RR…
RT @Steph_Achenbach: Benefit of low RR target linked to baseline CV risk: SPRINT (published 2015) in n=9361 showed benefit of targeting RR…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @Steph_Achenbach: Benefit of low RR target linked to baseline CV risk: SPRINT (published 2015) in n=9361 showed benefit of targeting RR…
Benefit of low RR target linked to baseline CV risk: SPRINT (published 2015) in n=9361 showed benefit of targeting RR 120 as compared to RR 140. Now SPRINT analysis in JACC: Benefit-to-harm ratio of low target only positive (>1) if CV risk above average
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @SIAC_cardio: Nuevos datos. Habrá que reescribir las guías? @fernando_wyss @DrPontecarlosi @gonzaeperez #SIACPREVENT https://t.co/MXreXy…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @SIAC_cardio: Nuevos datos. Habrá que reescribir las guías? @fernando_wyss @DrPontecarlosi @gonzaeperez #SIACPREVENT https://t.co/MXreXy…
We need a RCT for that kind of people https://t.co/0zLoAE6DBN
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
RT @JACCJournals: New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? htt…
Nuevos datos. Habrá que reescribir las guías? @fernando_wyss @DrPontecarlosi @gonzaeperez #SIACPREVENT https://t.co/MXreXy1Q0U
New analysis suggests intensive BP treatment may really only benefit those with 10yr CVD risk of 18.2%: Do you agree? https://t.co/aoczJgXljX #JACC https://t.co/GhPe52rOJl
@RichardJMcManus interesting study on benefit vs harm with abs. CVD risk and SBP thresholds https://t.co/5uu1PccfG1
RT @JACCJournals: Higher #CVD risk = higher benefit when it comes to intensive HTN treatment: https://t.co/QJDOALG5wp. #JACC https://t.co/2…
RT @JACCJournals: Higher #CVD risk = higher benefit when it comes to intensive HTN treatment: https://t.co/QJDOALG5wp. #JACC https://t.co/2…
RT @JACCJournals: Higher #CVD risk = higher benefit when it comes to intensive HTN treatment: https://t.co/QJDOALG5wp. #JACC https://t.co/2…
RT @JACCJournals: Higher #CVD risk = higher benefit when it comes to intensive HTN treatment: https://t.co/QJDOALG5wp. #JACC https://t.co/2…
RT @JACCJournals: Higher #CVD risk = higher benefit when it comes to intensive HTN treatment: https://t.co/QJDOALG5wp. #JACC https://t.co/2…
Higher #CVD risk = higher benefit when it comes to intensive HTN treatment: https://t.co/QJDOALG5wp. #JACC https://t.co/2GG9PUxRft
Parsing the new HTN guidelines - important analysis in JACC. Senior author is *private* cardiologist at our hospital, great to see! https://t.co/6XJXBlZ0Ag @aschuss @BPTHOSP https://t.co/RRrOE433he
RT @JCosinSales: Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/wkJTwAb…
RT @JACCJournals: Risk vs Benefit: Who benefits the most for intensive HTN treatment? https://t.co/M84msKnWCC #JACC https://t.co/gqiBCLb2RE
Interesting aggressive antihypertensive treatment not be the best strategy in those who have a low overall cardiovascular risk score https://t.co/uFixtHPSkx
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension | JACC "The predictive model demonstrated significantly increasing benefit-to-harm ratios... (p for trend <0.001)". https://t.co/3P9lsaSAj5
RT @JCosinSales: Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/wkJTwAb…
RT @hilariobad59: @JACCJournals Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https…
@JACCJournals Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/7ouwCp5oAY
RT @JACCJournals: Risk vs Benefit: Who benefits the most for intensive HTN treatment? https://t.co/M84msKnWCC #JACC https://t.co/gqiBCLb2RE
RT @JCosinSales: Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/wkJTwAb…
RT @JACCJournals: Risk vs Benefit: Who benefits the most for intensive HTN treatment? https://t.co/M84msKnWCC #JACC https://t.co/gqiBCLb2RE
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/OTupSeUstv
RT @JACCJournals: Risk vs Benefit: Who benefits the most for intensive HTN treatment? https://t.co/M84msKnWCC #JACC https://t.co/gqiBCLb2RE
RT @JCosinSales: Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/wkJTwAb…
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension https://t.co/wkJTwAbiZx
RT @JACCJournals: Risk vs Benefit: Who benefits the most for intensive HTN treatment? https://t.co/M84msKnWCC #JACC https://t.co/gqiBCLb2RE
RT @JACCJournals: Risk vs Benefit: Who benefits the most for intensive HTN treatment? https://t.co/M84msKnWCC #JACC https://t.co/gqiBCLb2RE
Risk vs Benefit: Who benefits the most for intensive HTN treatment? https://t.co/M84msKnWCC #JACC https://t.co/gqiBCLb2RE
RT @PhD_Leigh: Should #BloodPressure guidelines be categorized by #Cardiovascular risk for intensive #hypertension treatment? ❤️ https://t.…
Should #BloodPressure guidelines be categorized by #Cardiovascular risk for intensive #hypertension treatment? ❤️ https://t.co/RR5kuCJEPE 🏥 #PublicHealth #Cardiology #IntegrativeMedicine
RT @imconsortium: Researchers from Houston Methodist investigated the impact of new hypertension guidelines that redefine high blood pressu…
Researchers from Houston Methodist investigated the impact of new hypertension guidelines that redefine high blood pressure, finding that while patients at higher... https://t.co/Q1iLA7fsfy #thursdaythoughts #bloodpressure #cardiovasculardiseaserisk #treat
RT @svanwissen: Hypertension treatment in Sprint: patients with lower baseline CVD risk had more harm than benefit from intensive treatment…
RT @svanwissen: Hypertension treatment in Sprint: patients with lower baseline CVD risk had more harm than benefit from intensive treatment…
Hypertension treatment in Sprint: patients with lower baseline CVD risk had more harm than benefit from intensive treatment, whereas those with higher risk had more benefit #hypertension #Sprint https://t.co/QbiEvwPO7q
@EricTopol @PLOSMedicine Onother study with the same conclusions, based on SPRINT data Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension @JACCJournals https://t.co/LoUb1okc17
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
RT @mbotana: En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de l…
En el estudio SPRINT, cuanto mayor es el riesgo CV basal, mejor es la relación beneficio:riesgo del tratamiento intensivo de la HTA. https://t.co/8Ntn2vCC6S https://t.co/Dun9Mn29s2
"Those with lower baseline CVD risk had more harm than benefit from intensive treatment, whereas those with higher risk had more benefit" https://t.co/jdT6j6DMBr
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension. https://t.co/FIZMi6meFn
New NNT→Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension. https://t.co/P4COJBiHuR
RT @docdu16: poke @DDupagne https://t.co/6EnyndIhvT
RT @SpatzErica: Lower ASCVD risk people had more harm than benefit with intensive BP control. Higher ASCVD risk people derived more benefit…
RT @IlindelatorreMD: Las personas de menor riesgo para enfermedad cardiovascular aterosclerótica tuvieron más daño que beneficio con un con…
Las personas de menor riesgo para enfermedad cardiovascular aterosclerótica tuvieron más daño que beneficio con un control intensivo de la PA. Las personas de mayor riesgo obtuvieron más beneficios. https://t.co/y8ABHlF8uf https://t.co/y6WcMaR4y6
RT @SpatzErica: Lower ASCVD risk people had more harm than benefit with intensive BP control. Higher ASCVD risk people derived more benefit…
Kudos to Dr. Adam Schussheim (CS/NEMG/HVC) for his work on this paper evaluating Intensive HTN therapy and CV risk https://t.co/rYuRAu55FX
RT @SpatzErica: Lower ASCVD risk people had more harm than benefit with intensive BP control. Higher ASCVD risk people derived more benefit…